Cardlytics Inc Cash Flow Reinvestment Rate

Latest as of December 2025: 0.00x

Cardlytics Inc cash flow reinvestment rate. Cardlytics Inc (CDLX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting $25.00K (capex $25.00K ) from operating cash flow of $13.01 Million. Explore Cardlytics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$25.00K
Capex + Investments

Operating Cash Flow

$13.01 Million
USD

Capital Expenditures

$25.00K
USD

Cash Flow Reinvestment Rate of Cardlytics Inc (2019–2025)

Cash flow reinvestment rate of Cardlytics Inc from 2019 to 2025. Historical reinvestment intensity for Cardlytics Inc across 2 annual periods. Explore Cardlytics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Cardlytics Inc Cash Flow Reinvestment Rate by Year (2019–2025)

Cardlytics Inc cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Cardlytics Inc. For the full cash flow conversion analysis, see CDLX cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.05x $480.00K $9.29 Million $480.00K ▼ -97.3%
2019 1.92x $22.04 Million $11.46 Million $11.02 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow